AIMEE BROWN: Open Payments
NPI 1427456193 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 22 payments from 13 companies in 2025. Trend: 2023 $259 · 2024 $459 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc | 2 | $200 |
| E.R. Squibb & Sons, L.L.C. | 3 | $160 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| JAZZ PHARMACEUTICALS INC. | 2 | $47 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| Eisai Inc. | 2 | $37 |
| Astellas Pharma US Inc | 1 | $35 |
| ABBVIE INC. | 1 | $33 |
| Aveo Pharmaceuticals, Inc. | 1 | $26 |
Products named: XT CDX, OPDIVO, KISQALI, KEYTRUDA, Onivyde, Lenvima, Veozah, ELAHERE.
Industry payments across OH — which companies pay providers there.
